tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

WuXi AppTec Flags Strong 2025 Earnings Surge on CRDMO Growth and Investment Gains

Story Highlights
  • WuXi AppTec expects 2025 revenue to rise about 16 percent, with continuing operations up over 21 percent year-on-year.
  • Net profit attributable to shareholders is forecast to more than double in 2025, boosted by core growth and investment-related gains.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
WuXi AppTec Flags Strong 2025 Earnings Surge on CRDMO Growth and Investment Gains

Claim 50% Off TipRanks Premium

An update from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) is now available.

WuXi AppTec issued a positive profit alert, indicating it expects significant year-on-year growth in both revenue and earnings for the financial year ending 31 December 2025, based on preliminary figures prepared under Chinese accounting standards. The company forecasts revenue of about RMB45.46 billion, up 15.84% from 2024, with revenue from continuing operations rising roughly 21.40%, and adjusted non-IFRS net profit attributable to shareholders increasing 41.33% to around RMB14.96 billion. Net profit after deducting non-recurring items is projected to grow 32.56% to about RMB13.24 billion, while total net profit attributable to shareholders is expected to surge 102.65% to approximately RMB19.15 billion, driven in part by investment income from the sale of a partial interest in an associate and divestiture of certain business. The company highlights that its sustained growth is underpinned by its integrated CRDMO model and ongoing efficiency gains, while cautioning shareholders and potential investors to exercise care when dealing in its securities.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$111.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

More about WuXi AppTec Co., Ltd. Class H

WuXi AppTec Co., Ltd. is a China-based contract research, development and manufacturing organization (CRDMO) that provides integrated, end-to-end R&D and production services to global pharmaceutical and biotech clients. The group focuses on expanding capabilities and capacity, optimizing production processes and improving operating efficiency to meet ongoing customer demand and support the development of new therapies worldwide.

Average Trading Volume: 5,536,913

Technical Sentiment Signal: Buy

Current Market Cap: HK$323.4B

See more insights into 2359 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1